AI Article Synopsis
- Gastrointestinal cancers arise in eight distinct locations, each requiring a specific treatment approach.
- This article focuses on thirteen significant phase III randomized studies from 2020 that have changed clinical practice, rather than attempting a comprehensive review.
- The findings discussed have been presented at key oncology conferences, including ASCO and ESMO, highlighting their importance and impact on gastrointestinal cancer treatment.
Article Abstract
Gastrointestinal cancers occur in a total of eight different locations, each of them with a different standard of care. This article is not an exhaustive review of what has been published in 2020. We have concentrated on the thirteen phase III randomized studies that are practice-changing. All these studies are oral presentations which have been given in one of the four major oncology congresses, namely American Society of Clinical Oncology (ASCO), ASCO gastrointestinal (GI), European Society of Medical Oncology (ESMO) and ESMO-GI. We provide a concise view of these major trials and their main outcomes, and put these results into context.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326255 | PMC |
| http://dx.doi.org/10.3748/wjg.v27.i28.4493 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!